DK173586B1 - Fremgangsmåde til pasteuriseret af human-plasma-produkt - Google Patents
Fremgangsmåde til pasteuriseret af human-plasma-produkt Download PDFInfo
- Publication number
- DK173586B1 DK173586B1 DK198404061A DK406184A DK173586B1 DK 173586 B1 DK173586 B1 DK 173586B1 DK 198404061 A DK198404061 A DK 198404061A DK 406184 A DK406184 A DK 406184A DK 173586 B1 DK173586 B1 DK 173586B1
- Authority
- DK
- Denmark
- Prior art keywords
- plasma
- liter
- process according
- plasma product
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 108010094028 Prothrombin Proteins 0.000 claims abstract description 9
- 102100027378 Prothrombin Human genes 0.000 claims abstract description 9
- 229940039716 prothrombin Drugs 0.000 claims abstract description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- 102000004895 Lipoproteins Human genes 0.000 claims description 6
- 108090001030 Lipoproteins Proteins 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- -1 polyhydroxymethylene Polymers 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-Aminobutanoic acid Natural products CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- 229910021645 metal ion Inorganic materials 0.000 claims description 4
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 claims description 2
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 229960002591 hydroxyproline Drugs 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 229940000635 beta-alanine Drugs 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 229960002743 glutamine Drugs 0.000 claims 1
- 229960002429 proline Drugs 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 3
- 210000002381 plasma Anatomy 0.000 description 30
- 239000000243 solution Substances 0.000 description 17
- 238000009928 pasteurization Methods 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- 208000006454 hepatitis Diseases 0.000 description 7
- 102000004506 Blood Proteins Human genes 0.000 description 6
- 108010017384 Blood Proteins Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000004023 fresh frozen plasma Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000935 Antithrombin III Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 101000870363 Oryctolagus cuniculus Glutathione S-transferase Yc Proteins 0.000 description 1
- 102100038124 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 229910018540 Si C Inorganic materials 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 229960005348 antithrombin iii Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- External Artificial Organs (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Glass Compositions (AREA)
- Peptides Or Proteins (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3330770 | 1983-08-26 | ||
| DE19833330770 DE3330770A1 (de) | 1983-08-26 | 1983-08-26 | Verfahren zur pasteurisierung von humanplasma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK406184D0 DK406184D0 (da) | 1984-08-24 |
| DK406184A DK406184A (da) | 1985-02-27 |
| DK173586B1 true DK173586B1 (da) | 2001-04-02 |
Family
ID=6207474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198404061A DK173586B1 (da) | 1983-08-26 | 1984-08-24 | Fremgangsmåde til pasteuriseret af human-plasma-produkt |
Country Status (14)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3602688A1 (de) * | 1986-01-30 | 1987-08-06 | Behringwerke Ag | Verfahren zur gewinnung und herstellung eines pasteurisierten praeparates von (alpha)(pfeil abwaerts)2(pfeil abwaerts)-antiplasmin |
| AT390560B (de) * | 1986-05-30 | 1990-05-25 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
| US5248767A (en) * | 1986-06-11 | 1993-09-28 | Behringwerke Aktiengesellschaft | Process for the preparation of a pasteurized immunoglobulin preparation using ethanol |
| DE3619565A1 (de) * | 1986-06-11 | 1987-12-17 | Behringwerke Ag | Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation |
| CA1310267C (en) * | 1986-07-09 | 1992-11-17 | Yutaka Hirao | Process for heat treating chemically unmodified _-globulin |
| GB8710598D0 (en) * | 1987-05-05 | 1987-06-10 | Star Medical Diagnostics Ltd | Hemoglobin based blood substitute |
| US5844097A (en) * | 1990-11-30 | 1998-12-01 | Monoclonetics International, Inc. | Methods for the diagnosis of peripheral nerve damage |
| DK0559795T3 (da) * | 1990-11-30 | 1996-01-29 | Monoclonetics Int | Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen |
| DE4202667C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1992-01-29 | 1993-05-13 | Behringwerke Ag, 3550 Marburg, De | |
| FR2687317B1 (fr) * | 1992-02-13 | 1995-06-23 | Aetsrn | Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique. |
| AT400199B (de) * | 1993-10-11 | 1995-10-25 | Immuno Ag | Aufbereitung von lipoproteinhältigen proben |
| DE19856443A1 (de) * | 1998-12-08 | 2000-06-21 | Centeon Pharma Gmbh | Stabilisiertes Antithrombin III-Präparat |
| DE10012732A1 (de) * | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
| US7931919B2 (en) * | 2005-08-12 | 2011-04-26 | The United States Of America As Represented By The Secretary Of The Army | Method of producing glycine-stabilized, lyophilized plasma |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6702923A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1966-04-06 | 1967-10-09 | ||
| DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
| DE3176491D1 (en) * | 1980-03-05 | 1987-11-26 | Miles Lab | Pasteurized therapeutically active protein compositions |
| JPS56135418A (en) * | 1980-03-27 | 1981-10-22 | Green Cross Corp:The | Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human |
| DE3033932C2 (de) * | 1980-09-10 | 1984-05-24 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten |
| DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
| DE3101752A1 (de) * | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen" |
| JPS5874617A (ja) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | 人由来血液凝固第７因子含有水溶液の加熱処理方法 |
| DE3237512A1 (de) * | 1982-10-09 | 1984-04-12 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat |
-
1983
- 1983-08-26 DE DE19833330770 patent/DE3330770A1/de not_active Withdrawn
-
1984
- 1984-08-21 AT AT84109915T patent/ATE44877T1/de active
- 1984-08-21 EP EP84109915A patent/EP0139975B1/de not_active Expired
- 1984-08-21 DE DE8484109915T patent/DE3479086D1/de not_active Expired
- 1984-08-23 PT PT79117A patent/PT79117B/pt not_active IP Right Cessation
- 1984-08-23 GR GR80183A patent/GR80183B/el unknown
- 1984-08-24 US US06/643,720 patent/US4579735A/en not_active Expired - Lifetime
- 1984-08-24 AU AU32391/84A patent/AU561222B2/en not_active Ceased
- 1984-08-24 ZA ZA846611A patent/ZA846611B/xx unknown
- 1984-08-24 CA CA000461821A patent/CA1236013A/en not_active Expired
- 1984-08-24 DK DK198404061A patent/DK173586B1/da not_active IP Right Cessation
- 1984-08-24 JP JP59175333A patent/JPS6072818A/ja active Granted
- 1984-08-24 ES ES535409A patent/ES8505254A1/es not_active Expired
- 1984-08-24 IL IL72761A patent/IL72761A/xx unknown
- 1984-08-24 IE IE2180/84A patent/IE57902B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0139975B1 (de) | 1989-07-26 |
| CA1236013A (en) | 1988-05-03 |
| DE3330770A1 (de) | 1985-03-14 |
| IL72761A0 (en) | 1984-11-30 |
| IL72761A (en) | 1988-08-31 |
| PT79117B (de) | 1986-09-15 |
| DE3479086D1 (en) | 1989-08-31 |
| JPS6072818A (ja) | 1985-04-24 |
| ATE44877T1 (de) | 1989-08-15 |
| AU561222B2 (en) | 1987-04-30 |
| EP0139975A1 (de) | 1985-05-08 |
| DK406184D0 (da) | 1984-08-24 |
| GR80183B (en) | 1985-01-02 |
| ES535409A0 (es) | 1985-05-16 |
| DK406184A (da) | 1985-02-27 |
| IE57902B1 (en) | 1993-05-05 |
| JPH0530811B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-05-11 |
| AU3239184A (en) | 1985-02-28 |
| IE842180L (en) | 1985-02-26 |
| PT79117A (de) | 1984-09-01 |
| ZA846611B (en) | 1985-04-24 |
| US4579735A (en) | 1986-04-01 |
| ES8505254A1 (es) | 1985-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK173586B1 (da) | Fremgangsmåde til pasteuriseret af human-plasma-produkt | |
| AU759145B2 (en) | Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma | |
| JP4841018B2 (ja) | 生物学的製品の最終滅菌法 | |
| US4687664A (en) | Method of inactivating reproducible pathogens | |
| US4216205A (en) | Process of preparing a serum protein composition for intravenous application | |
| US20080242844A1 (en) | Ultra-high Yield Intravenous Immune Globulin Preparation | |
| US4379085A (en) | Heat stabilization of plasma proteins | |
| US7879332B2 (en) | Ultra-high yield intravenous immune globulin preparation | |
| US4562072A (en) | Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby | |
| RU2112522C1 (ru) | Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии | |
| DK163107B (da) | Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed | |
| JPS6160614A (ja) | 第８因子製剤およびその製造方法 | |
| US4739039A (en) | Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product | |
| JP2879427B2 (ja) | ウイルスおよびバクテリア汚染物の熱的不活性化中の生物学的および製薬的生成物の安定化 | |
| AU772669B2 (en) | Process for the inactivation of viruses | |
| PT94859B (pt) | Processo para a pasteurizacao de uma mistura de proteinas contendo fibrinogenio | |
| RU2253475C1 (ru) | Способ получения препарата фактора viii | |
| FI96918B (fi) | Koostumus veriplasman stabiloimiseksi pastöroinnin aikana | |
| JPS60155120A (ja) | 血漿製剤の製法 | |
| Allersma et al. | Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |